Replies to post #108451 on Biotech Values

[ghmm]

Yeah I went back and highlighted that section :-)

Also while some may see it as negative I don't and really like this

Richard Adams, a former official in the FDA's generic-drug division who
retired this year, agreed with the bias allegation. "Everyone closely involved
saw that it was stacked and the whole direction was toward Momenta," he said.

BTW, Feel free to delete my post and repost if you want to redo with annotations/highlighting

[DragonBits]

Dew, glad I don't try and trade options on MNTA, everything seems so positive yet the stock trades so poorly technically. I am sure I would guess wrong too often.

I believe MNTA is a good long term buy and should get to the 3 billion market cap+, but it sure trades like a dog right now. Not at all sure why, I would buy if TEVA got approval at whatever price MNTA was trading at after an announcement. But it also looks like TEVA will not get approval.

Do you have any guesses as to why MNTA trades poorly?